Pharmaceutical Training Course Calendar

Back to details

Training format

Topic

Our Pharmaceutical calendar for the next 12 months:

Live online Classroom 2026 2027
Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct

A Practical Guide to Producing and Maintaining the PSMF & Annexes

Vigilance 5 15

A Practical Guide to Writing Risk Management Plans (RMPs)

Vigilance 19 18

A Practical Introduction to Good Clinical Practice (GCP)

New for 2027

GxP 14 5

AI & ML in Clinical Trials: Fundamentals, Applications, and Regulatory Aspects

Artificial Intelligence (AI) in Life Sciences 10

AI in Pharmacovigilance

Artificial Intelligence (AI) in Life Sciences 17

APIs in Focus: Understanding ICH, GMP and Supply Chain Excellence

GxP 28-29 20-21

Additional Risk Minimization Measures (aRMMs) and Their Effectiveness

Vigilance 2 15

Advanced GMP & GDP Auditor Masterclass

New for 2027

GxP 12-14 12-14

Advanced Pharmacovigilance: From Performing Successful Due Diligence to Benefit-Risk Assessments – What to Consider

Vigilance 1-3 20-24

An Essential Overview of Medical Information

Regulatory Affairs 21

An Introduction to Human Factors for Pharmaceutical and Medical Device Professionals

Medical Devices 7

An Overview of EU and UK Regulatory Affairs

Regulatory Affairs 3-4 20-21

Antimicrobial Resistance (AMR) and 'One Health': Current Challenges, Regulatory Frontiers and Future Solutions

New for 2027

Regulatory Affairs 9

Behavioural Risk Management in Clinical Trials

New for 2027

Clinical Research 15 19

Best Practices for Supplier Qualification in Life Science

Medical Devices 26-27

Biosimilars

Biopharma 15-16 20-21

Biotechnology for the Non-Biotechnologist

Biopharma 9-11

CAPA (Corrective and Preventative Action)

Regulatory Affairs 14

Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products

GxP 22-23 18-19

Cleaning Validation - Best Practice in Pharmaceuticals

GxP 22-23

Clinical & Post-Marketing Safety

Vigilance 10-11

Clinical Overview and Clinical Summary: Creating Effective Marketing Authorisation Applications

Regulatory Affairs 3-4 29-30

Clinical Quality Management Systems (CQMS): A Practical Guide to Inspection Readiness

Clinical Research 15-16 16-17

Clinical Research Project Management

Leadership & Management for Life Sciences 28-30 20-22

Clinical Trial Agreements: Key Legal, Regulatory and IP Considerations for the EU and UK Markets

Commercial Contracts 12

Clinical Trial Monitoring

Clinical Research 17-18

Clinical Trial Regulatory Requirements

Clinical Research 1-2 23-24

Clinical Trials in the MENA Region

New for 2027

Clinical Research 26

Competition Law for the Pharmaceutical Industry

Commercial Contracts 26 8

Cosmetovigilance

Cosmetics 10-11 17-18

Data Integrity and Document Management

Medical Devices 21

Data-Driven Process Control: Statistical Process Control (SPC) Tools for Quality, Stability, and Performance

New for 2027

GxP 24-25 27-28

Dealing With Scientific Journal Reviewers: From Comments to Resubmission

New for 2026

Medical Devices 1

Development of Combination Products: Critical Interactions

GxP 8-9 15-16

Drafting Commercial Contracts for the Pharmaceutical Industry

Commercial Contracts 19-20

EU Pharmaceutical Regulations and Strategy

Regulatory Affairs 1-2 4-5

EU Proposed Pharmaceutical Legislation Changes

Regulatory Affairs 18 7

Effective Technical Writing & Editing

Medical Writing 14

Effective Technology Transfer

GxP 8-9 7-8

GMP Advanced Masterclass for Pharmaceutical and Biotechnology Industries

New for 2027

GxP 7-9

GMP Principles in Vaccine Manufacturing

GxP 15-16

Good Distribution Practices of Pharmaceuticals and APIs

GxP 20-21

How the Pharmaceutical and Biotech Industries Work: From Molecule to Market

Regulatory Affairs 11 27

ICH Q12: Advanced Pharmaceutical Product Lifecycle Management in Practice

New for 2027

GxP 18-19 7-8

ICH Q9(R1) Quality Risk Management (QRM)

Updated for 2027

GxP 24

Integrating AI into the GMP Environment

New for 2027

Artificial Intelligence (AI) in Life Sciences 7

Literature Searching in Drug Safety

Vigilance 13-14

Managing Service Providers including CRO and CMOs oversight to comply with ICH GCP R3

Animal Health 12-13 14-15

Mastering CTD Submissions in the MENA Region

Regulatory Affairs 25

Mastering Computer System Validation

GxP 16-17

Measuring Performance in Clinical Research Management

Clinical Research 17

Microbiomics in Clinical Trials

New for 2027

Clinical Research 25 17

Molecular Biology from Fundamentals to the Latest Applications

Biopharma 19-20 7-8

Navigating EU Product Classification: Foods, Supplements & Herbal Medicines Masterclass

Updated for 2027

Regulatory Affairs 10

New EU GMP Annex 1: Compliant Sterile Medicinal Products

GxP 28-30 4-6

Orphan Drug Regulatory Masterclass: EU & US Insights

Regulatory Affairs 3 28

Pharma Facility Project Management: Delivering GMP‑Compliant Sites On Time and Within Budget

New for 2027

GxP 8-9 15-16

Pharmaceutical Development of ATMPs

GxP 17-18 27-28

Pharmaceutical Packaging Essentials: From Regulatory Compliance to Market Success

GxP 17-19 21-23

Pharmaceutical Regulatory Affairs in Asia

Regulatory Affairs 3-5 19-21

Pharmaceutical Regulatory Affairs in China

Regulatory Affairs 25-26 19-20

Pharmaceutical Regulatory Affairs in Russia, Eurasian Union and the CIS

Regulatory Affairs 4-5 29-30

Pharmaceutical Regulatory Affairs in the Middle East

Regulatory Affairs 12-13 19-20

Pharmaceutical Regulatory Affairs in the Middle East and North Africa

Regulatory Affairs 7-9

Pharmacovigilance Aspects of Licensing Agreements

Vigilance 9 30

Pharmacovigilance QMS & Inspection Preparation

Vigilance 26-27 7-8

Pharmacovigilance: An Overview of Drug Safety from Safety Collection to Regulatory Inspection

Vigilance 29 4

Practical Risk Management in Clinical Research and Trials

Clinical Research 23 5

Preparing for GCP Inspections: Key Expectations under ICH GCP E6(R3), EU CTR and Current Regulatory Thinking

Clinical Research 25

Process Validation with Qualification

GxP 14-15

Protein Engineering for Pharmaceutical Biotechnology

New for 2027

Biopharma 2-3 21-22

Signal Detection and Regulatory Expectations

Vigilance 25-26 29-30

Smart Packaging and Electronic Patient Information

Medical Devices 20

Stability Testing of Pharmaceuticals and Biopharmaceuticals

GxP 19-21

Successful Medical Writing – from Protocol to CTD

Medical Writing 11-12 21-22

The 2024 EU AI Act

Artificial Intelligence (AI) in Life Sciences 22

The Common Technical Document

GxP 13-14 20-21

The FDA Drug Approval Process

Regulatory Affairs 22-23 23-24

The Principles & Applications of CRISPR

New for 2027

Biopharma 22 6

The Regulatory Requirements on Nitrosamines in the Pharmaceutical Industry

Regulatory Affairs 19-20 11-12

Thinking Beyond Traditional GMP

GxP 9-10 15-16

US FDA - Understanding Key Factors When Working with the FDA

Biopharma 19 7

Understanding Pharmacovigilance Regulations in China

New for 2027

Vigilance 27 11

Variations to Marketing Authorisations

Regulatory Affairs 14-15

Writing Inspection-Ready SOPs: Best Practice for Compliance and Control

Regulatory Affairs 26 6